|
STARD3NL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.512745649914E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63014046705712E-12 |
| Normal-vs-Stage2 |
5.426900E-04 |
| Normal-vs-Stage3 |
7.376600E-04 |
| Normal-vs-Stage4 |
9.969100E-04 |
| Stage1-vs-Stage2 |
6.694000E-01 |
| Stage1-vs-Stage3 |
2.332400E-02 |
| Stage1-vs-Stage4 |
3.673700E-02 |
| Stage2-vs-Stage3 |
2.831400E-01 |
| Stage2-vs-Stage4 |
3.268800E-01 |
| Stage3-vs-Stage4 |
9.180200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.29150032282632E-13 |
| Normal-vs-AfricanAmerican |
9.983500E-03 |
| Normal-vs-Asian |
1.394020E-01 |
| Caucasian-vs-AfricanAmerican |
1.015000E-01 |
| Caucasian-vs-Asian |
8.426200E-01 |
| AfricanAmerican-vs-Asian |
3.547200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.40940001283718E-09 |
| Normal-vs-Female |
2.7778890299146E-12 |
| Male-vs-Female |
1.586250E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.352300E-02 |
| Normal-vs-Age(41-60Yrs) |
4.77460004866259E-09 |
| Normal-vs-Age(61-80Yrs) |
9.20463705256225E-12 |
| Normal-vs-Age(81-100Yrs) |
2.787600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.619400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.373800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.117800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.103400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.898800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.780000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.361700E-03 |
| Normal-vs-Grade 2 |
1.66533453693773E-14 |
| Normal-vs-Grade 3 |
4.00570000502753E-08 |
| Normal-vs-Grade 4 |
1.229360E-01 |
| Grade 1-vs-Grade 2 |
4.212400E-01 |
| Grade 1-vs-Grade 3 |
6.901800E-02 |
| Grade 1-vs-Grade 4 |
8.099200E-03 |
| Grade 2-vs-Grade 3 |
1.277740E-02 |
| Grade 2-vs-Grade 4 |
1.605660E-04 |
| Grade 3-vs-Grade 4 |
2.677800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
9.203300E-03 |
| ccA subtype-vs-ccB subtype |
2.19469997730926E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.66808838648103E-12 |
| Normal-vs-N1 |
3.244000E-01 |
| N0-vs-N1 |
2.169800E-01 |
|
|
